最新一批74萬劑德國製復必泰疫苗付運抵港
政府公布,復星醫藥(02196.HK)已於今日(14日)將BioNTech(BNTX.US)製造、於德國另一廠房Baxter封裝的最新一批復必泰疫苗付運抵港,涉及約74萬劑。
新一批次復必泰疫苗抵港後,工作人員隨即按既定程序檢查及核對有關疫苗進行,以確保疫苗符合產品規格及相關的冷鏈運輸標準,並會把疫苗存放在經驗證的超低溫冷藏櫃,按藥廠指定的溫度妥善保存。
政府表示,此批疫苗的藥瓶標籤包含英文及簡體中文,但有關批次均由相同製造商及廠房以相同規格在德國製造及封裝。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.